Ligand validation:7E01

PRO: PROLINE

PRO is a Ligand Of Interest in 7E01 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7E01_PRO_A_301	41%	30%	0.158	0.873	1.38	1.42	2	2	6	0	100%	1
8H7Y_PRO_B_303	76%	53%	0.136	0.973	0.85	0.97	1	-	0	0	100%	1
7E00_PRO_B_701	72%	38%	0.134	0.957	1.03	1.39	1	2	0	0	100%	1
7E07_PRO_A_502	67%	44%	0.13	0.939	0.72	1.43	-	2	0	0	100%	1
7DZZ_PRO_B_301	64%	26%	0.123	0.922	1.04	1.95	1	3	1	0	100%	1
7DT0_PRO_A_503	56%	40%	0.159	0.931	0.66	1.66	-	2	0	0	100%	1
4N1M_PRO_A_202	100%	55%	0.042	0.992	0.49	1.24	-	1	0	0	100%	1
5MC1_PRO_A_504	96%	42%	0.071	0.978	0.84	1.38	-	2	0	0	100%	1
6MNI_PRO_A_301	94%	49%	0.067	0.968	0.78	1.16	-	1	0	0	100%	1
4UFB_PRO_C_1304	94%	39%	0.075	0.975	0.81	1.54	1	2	0	0	100%	1
2AMF_PRO_C_4331	93%	52%	0.079	0.975	0.67	1.17	-	1	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.